CHEMOTHERAPY WITH FUDR IN THE MANAGEMENT OF METASTATIC RENAL-CELL CARCINOMA

Citation
P. Aveta et al., CHEMOTHERAPY WITH FUDR IN THE MANAGEMENT OF METASTATIC RENAL-CELL CARCINOMA, Annales d'Urologie, 31(3), 1997, pp. 159-163
Citations number
23
Categorie Soggetti
Urology & Nephrology
Journal title
ISSN journal
00034401
Volume
31
Issue
3
Year of publication
1997
Pages
159 - 163
Database
ISI
SICI code
0003-4401(1997)31:3<159:CWFITM>2.0.ZU;2-4
Abstract
Metastatic renal cell carcinoma has a poor prognosis, requiring system ic therapy, in addition to radical nephrectomy. Since August 1989, 50 patients were treated with continuous, systemic, chronobiological infu sion of FUDR (floxuridine) at our Institution. We reported 11.7 % of o bjective responses, a long period of stable disease and low toxicity. We also compared our actuarial survival with the results obtained with recombinant IL-2 treatment.